Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era

Erin E Doherty, MD, Michele Redell, MD, Ghadir Sasa, MD, Khaled Yassine, MD, Tami D John, MD, John Craddock, Mengfen Wu, MS, Tao Wang, PhD, Caridad A. Martinez, MD, Robert A. Krance, MD, Swati Naik, MBBS

Blood (2019) 134 (Supplement_1): 2056.

https://doi.org/10.1182/blood-2019-131131

Published: 2019

Journal Articles

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

Blood (2018) 132 (Supplement 1): 603.

https://doi.org/10.1182/blood-2018-99-110599

Published: 2018

Journal Articles

Immune Mediated Cytopenia's Following Cord Blood Transplantation for Hurler's Syndrome: A Failure of Pre-Transplant Immune Suppression

David Deambrosis, MBBS, FRACP, Ryan Hum, Prashant Hiwarkar, Kay Poulton, Denise Bonney, Helen Jane Campbell, FRCP, MD FRCPath, Robert Wynn, MD

Blood (2018) 132 (Supplement 1): 3374.

https://doi.org/10.1182/blood-2018-99-112995

Published: 2018

Journal Articles

Replacement of Polyclonal Anti-Thymocyte Globulin By Targeted Immunomodulation Is Associated with Improved Outcome of Alfa\Beta T Cell-Depleted Hematopoietic Stem Cells Transplantation in Children with Acute Leukemia

Blood (2018) 132 (Supplement 1): 481.

https://doi.org/10.1182/blood-2018-99-116007

Published: 2018

Journal Articles

Outcomes of Pediatric Patients with Acute Leukemia Following Adult Unrelated Donor Transplant: The Impact of Donor KIR Gene Content and KIR Ligand Matching

Michael R Verneris, MD, Tao Wang, PhD, Stephen R. Spellman, Jennifer A. Sees, MPH, Michael D. Haagenson, MS, Sarah Cooley, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, Katharina Fleischhauer, Dean Anthony Lee, MD PhD, Sophie Paczesny, MD PhD, Hemalatha G. Rangarajan, MD, Jeffrey S. Miller, MD, Stephanie J. Lee, MD MPH

Blood (2018) 132 (Supplement 1): 4647.

https://doi.org/10.1182/blood-2018-99-116428

Published: 2018

Journal Articles

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Related Transplantation in b Thalassaemia Major Leads to Early and Sustained Engraftment with Low Incidence of VOD and GvHD but a High Rate of Long-Term Mixed Chimerism

Farah O'Boyle, PhD, Leena Karnik, FRCPath, MRCP, Kirstin Lund, MRCP, BSc, Richard Szydlo, PhD, Josu de la Fuente, FRCP, PhD FRCPath

Blood (2017) 130 (Supplement 1): 3323.

https://doi.org/10.1182/blood.V130.Suppl_1.3323.3323

Published: 2017

Journal Articles

Hematopoietic Stem Cell Transplantation in 65 Patients with Leukocyte Adhesion Deficiency Type I and Type III — A Retrospective Multi-Center Study

Blood (2017) 130 (Supplement 1): 3330.

https://doi.org/10.1182/blood.V130.Suppl_1.3330.3330

Published: 2017

Journal Articles

Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Peter J. Lang, MD, Friedhelm Schuster, Bernd Gruhn, Roland Meisel, MD, Patrick Schlegel, MD, Anne-Marie Lang, Chihab Klose, Wolfgang Schwinger, MD, Tobias F. Feuchtinger, Prof. Dr. MD, Heiko-Manuel Teltschik, Holger Martinius, Michael Schumm, DVM, Rupert Handgretinger, MD

Blood (2017) 130 (Supplement 1): 3250.

https://doi.org/10.1182/blood.V130.Suppl_1.3250.3250

Published: 2017

Journal Articles

Excellent Outcome of Alternative Donor HSCT in Fanconi Anemia Using Chemotherapy Only Regimen: Single Korean Institution Experience

Seong-koo Kim, MD, Jae Wook Lee, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho, MD PhD, Jong-Wook Lee, MD

Blood (2017) 130 (Supplement 1): 5556.

https://doi.org/10.1182/blood.V130.Suppl_1.5556.5556

Published: 2017

Journal Articles

Outcomes of Unrelated Cord Blood Transplantation for Familial Hemophagocytic Lymphohistiocytosis: Risk Factors and Long Term Follow-up. an Analysis on Behalf of Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology Working Party of the EBMT and Inborn Errors Working Party of the EBMT

Juliana Montibeller Furtado E Silva, MD, Annalisa Paviglianiti, MD, Annalisa Ruggeri, MD, Jaap Jan Boelens, MD PhD, Paul Veys, MD PhD, Ali Abdallah Ahmari, Franco Locatelli, MD PhD, Gerard Michel, MD, Fernanda Volt, Chantal Kenzey, Petr Sedlacek, MD, Kanchan Rao, Arjan Lankester, MD PhD, Eliane Gluckman, Vanderson Rocha, MD PhD

Blood (2017) 130 (Supplement 1): 2049.

https://doi.org/10.1182/blood.V130.Suppl_1.2049.2049

Published: 2017

Journal Articles

Alpha/Beta T Cell Depleted Haploidentical Transplantation Results in High Survival in Pediatric Patients with Acute Myeloid Leukemia

Larisa Shelikhova, Maria Ilushina, Zhanna Shekhovtsova, MD, Elena Kurnikova, Galina Novichkova, Alexey A Maschan, MD PhD Professor, Michael Maschan, MDMSc

Blood (2017) 130 (Supplement 1): 4580.

https://doi.org/10.1182/blood.V130.Suppl_1.4580.4580

Published: 2017

Journal Articles

Haemopoietic Stem Cell Transplantation for Diamond Blackfan Anaemia Leads to Early and Sustained Engraftment with Good Long-Term Outcomes, but Has an Increased Risk of Gut Toxicity and Lung GvHD

Farah O'Boyle, PhD, Anne Bradshaw, Richard M Szydlo, Josu de la Fuente, PhD FRCP, FRCPI, FRCPCH, FRCPath

Blood (2016) 128 (22): 2679.

https://doi.org/10.1182/blood.V128.22.2679.2679

Published: 2016

Journal Articles

High-Exposure, Targeted Daily Busulfan and Fludarabine-Based Conditioning for Children Undergoing Hematopoietic Stem Cell Transplantation for Inherited Metabolic Disorders: Outcomes at a Single Center

Weston P Miller, Melisa Kay Stricherz, PharmD, Cathryn Jennissen, PharmD, Nicole Sando, Jennifer Danielson, Troy Lund, Paul J Orchard

Blood (2016) 128 (22): 2191.

https://doi.org/10.1182/blood.V128.22.2191.2191

Published: 2016

Journal Articles

Lineage Switch Under Blinatumomab of a Relapsed Common ALL Co-Expressing Myeloid Markers without MLL Rearrangement

Annabel Zoghbi, Beate Winkler, MD, Udo zur Stadt, PhD, Ingo Müller, MD, Gabriele Escherich, MD

Blood (2016) 128 (22): 5196.

https://doi.org/10.1182/blood.V128.22.5196.5196

Published: 2016

Journal Articles

The Changing Patterns of Graft Failure in MPS1H, Hurler Syndrome: A Review of 30-Years Experience

Su Han Lum, Weston P Miller, Simon Jones, Jean Mercer, Troy Lund, Denise Bonney, Paul J Orchard, Robert Wynn

Blood (2016) 128 (22): 4700.

https://doi.org/10.1182/blood.V128.22.4700.4700

Published: 2016

Journal Articles

Impact of Different In Vivo T Cell Depletion Strategies on Outcomes Following Hematopoietic Stem Cell Transplantation for Idiopathic Aplastic Anaemia: A Study on Behalf of the EBMT SAA Working Party

Sujith Samarasinghe, MD PhD, Simona Iacobelli, Cora Knol, Rose-Marie Hamladji, Gerard Socie, MD PhD, Mahmoud Aljurf, MD MPH, Mickey Koh, MD, Henrik Sengeloev, Jean-Hugues Dalle, PhD MD, Stephen Robinson, Andrea Bacigalupo, MD, Joan H Veelken, Dietrich Beelen, MD, Ghulam J Mufti, FRCP, FRCPath, John A Snowden, MD FRCP, FRCPath, Didier Blaise, MD PhD, Judith C.W. Marsh, MD, Carlo Dufour, MD, Antonio M Risitano, MD PhD

Blood (2015) 126 (23): 1210.

https://doi.org/10.1182/blood.V126.23.1210.1210

Published: 2015

Journal Articles

Excellent Outcomes in Children and Young Adults Using Reduced-Intensity Conditioning for Patients with Inborn Errors of Immunity, Hematopoiesis, and Metabolism with Single-Unit Cord Blood or Bone Marrow

Mark Vander Lugt, MD, Hey Jin Chong, MD PhD, Xiaohua Chen, MDPhD, Randy M. Windreich, MD, Rakesh Goyal, MD MRCP, Maria Escolar, MD, Paul Szabolcs, MD

Blood (2015) 126 (23): 4329.

https://doi.org/10.1182/blood.V126.23.4329.4329

Published: 2015

Journal Articles

Outcomes after Donor Lymphocyte Infusion for Insufficient Donor Chimerism Following Hematopoietic Cell Transplantation for Non-Malignant Disorders

Carter Biewen, BA, Angela R Smith, MD MS, Jakub Tolar, MD, PhD, Weston P Miller, IV, MD

Blood (2015) 126 (23): 1969.

https://doi.org/10.1182/blood.V126.23.1969.1969

Published: 2015

Journal Articles

Risk Factors Affecting Outcome of Transplantation in Pediatric Acute Lymphoblastic Leukemia: Results of the International BFM ALL SCT Study

Adriana Balduzzi, MD, Jean-Hugues Dalle, MD PhD, Arjan C Lankester, MD PhD, Isaac Yaniv, MD, Akif Yesilipek, MD, Petr Sedlacek, MD PhD, Marianne Ifversen, MD, Sabina Sufliarska, MD, Marc B Bierings, MDPhD, Jacek Wachowiak, Prof MDPhD, Jacek Toporski, MD PhD, Ulrike Poetschger, Evgenia Glogova, Ingeborg Hirsch, BS, Christina Peters, MD PhD

Blood (2015) 126 (23): 2015.

https://doi.org/10.1182/blood.V126.23.2015.2015

Published: 2015

Journal Articles

In Vivo T Cell Depletion with Thymoglobulin or Alemtuzumab Is Associated with Worse Outcome Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients Transplanted in Remission

Scott R. Solomon, MD, Melissa Sanacore, Pharm.D., Xu Zhang, PhD, Katelin Connor, Melhem Solh, MD, Lawrence E. Morris, MD, H. Kent Holland, MD, Asad Bashey, MD PhD

Blood (2015) 126 (23): 3115.

https://doi.org/10.1182/blood.V126.23.3115.3115

Published: 2015

NARROW

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

Immune Mediated Cytopenia's Following Cord Blood Transplantation for Hurler's Syndrome: A Failure of Pre-Transplant Immune Suppression

Replacement of Polyclonal Anti-Thymocyte Globulin By Targeted Immunomodulation Is Associated with Improved Outcome of Alfa\Beta T Cell-Depleted Hematopoietic Stem Cells Transplantation in Children with Acute Leukemia

Outcomes of Pediatric Patients with Acute Leukemia Following Adult Unrelated Donor Transplant: The Impact of Donor KIR Gene Content and KIR Ligand Matching

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Related Transplantation in b Thalassaemia Major Leads to Early and Sustained Engraftment with Low Incidence of VOD and GvHD but a High Rate of Long-Term Mixed Chimerism

Hematopoietic Stem Cell Transplantation in 65 Patients with Leukocyte Adhesion Deficiency Type I and Type III — A Retrospective Multi-Center Study

Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Excellent Outcome of Alternative Donor HSCT in Fanconi Anemia Using Chemotherapy Only Regimen: Single Korean Institution Experience

Outcomes of Unrelated Cord Blood Transplantation for Familial Hemophagocytic Lymphohistiocytosis: Risk Factors and Long Term Follow-up. an Analysis on Behalf of Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology Working Party of the EBMT and Inborn Errors Working Party of the EBMT

Alpha/Beta T Cell Depleted Haploidentical Transplantation Results in High Survival in Pediatric Patients with Acute Myeloid Leukemia

Haemopoietic Stem Cell Transplantation for Diamond Blackfan Anaemia Leads to Early and Sustained Engraftment with Good Long-Term Outcomes, but Has an Increased Risk of Gut Toxicity and Lung GvHD

High-Exposure, Targeted Daily Busulfan and Fludarabine-Based Conditioning for Children Undergoing Hematopoietic Stem Cell Transplantation for Inherited Metabolic Disorders: Outcomes at a Single Center

Lineage Switch Under Blinatumomab of a Relapsed Common ALL Co-Expressing Myeloid Markers without MLL Rearrangement

The Changing Patterns of Graft Failure in MPS1H, Hurler Syndrome: A Review of 30-Years Experience

Impact of Different In Vivo T Cell Depletion Strategies on Outcomes Following Hematopoietic Stem Cell Transplantation for Idiopathic Aplastic Anaemia: A Study on Behalf of the EBMT SAA Working Party

Excellent Outcomes in Children and Young Adults Using Reduced-Intensity Conditioning for Patients with Inborn Errors of Immunity, Hematopoiesis, and Metabolism with Single-Unit Cord Blood or Bone Marrow

Outcomes after Donor Lymphocyte Infusion for Insufficient Donor Chimerism Following Hematopoietic Cell Transplantation for Non-Malignant Disorders

Risk Factors Affecting Outcome of Transplantation in Pediatric Acute Lymphoblastic Leukemia: Results of the International BFM ALL SCT Study

In Vivo T Cell Depletion with Thymoglobulin or Alemtuzumab Is Associated with Worse Outcome Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients Transplanted in Remission

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only